who should avoid glp 1 GLP-1 Medications Clinic Near Me in Fayetteville, NC The GLP-1 Agonists and Obesity:

A 2023 post-hoc analysis of the STEP program published in Diabetes Care found that participants with higher baseline insulin resistance derived greater metabolic benefit from semaglutide treatment, even when their HbA1c was below 5.7% at enrollment [14]

Maybe its an opportunity to have a discussion about maybe slowing down on the weight loss, maybe holding at a lower dose of the medication to give the body time to adjust, Dr

Depending on health history, monitoring may also include blood glucose, kidney function when fluid loss is a concern, diabetic retinopathy follow-up, and review of planned procedures involving anesthesia or deep sedation

Role of physical exercise, microbiota and myokines